Page last updated: 2024-08-26

mci 9038 and Left Heart Hypoplasia Syndrome

mci 9038 has been researched along with Left Heart Hypoplasia Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boshkov, L; Giacomuzzi, C; Heller, E; Mejak, B; Shen, I; Ungerleider, R; You, X1
Boshkov, LK; Kirby, A; Shen, I; Ungerleider, RM1

Reviews

1 review(s) available for mci 9038 and Left Heart Hypoplasia Syndrome

ArticleYear
Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients.
    The Annals of thoracic surgery, 2006, Volume: 81, Issue:6

    Topics: Adolescent; Anticoagulants; Arginine; Autoantibodies; Cardiopulmonary Bypass; Child; Child, Preschool; Clinical Trials as Topic; Fatal Outcome; Female; Heart Defects, Congenital; Heparin; Hirudins; Hospitals, University; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Multicenter Studies as Topic; Pipecolic Acids; Platelet Factor 4; Postoperative Complications; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome

2006

Other Studies

1 other study(ies) available for mci 9038 and Left Heart Hypoplasia Syndrome

ArticleYear
Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia.
    The journal of extra-corporeal technology, 2004, Volume: 36, Issue:2

    Topics: Anticoagulants; Arginine; Blood Coagulation; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Fatal Outcome; Heparin; Humans; Hypoplastic Left Heart Syndrome; Infant, Newborn; Pipecolic Acids; Postoperative Care; Sulfonamides; Thrombocytopenia

2004